Louis Lehot Featured in National Association of Corporate Directors Spotlight Series
12 July 2023
National Association of Corporate Directors
Foley & Lardner LLP partner Louis Lehot is featured as part of the National Association of Corporate Directors Partner Spotlight Series.
In the Q&A, Lehot examines some of the developing issues he advises board directors to be prepared for, provides guidance for directors to ensure they are well-prepared for upcoming challenges, and offers insight on how Foley is adding value for corporate board members through training and education, timely legal, market, and regulatory updates, and regular events that bring to together directors and investors to help propel them forward into new opportunities.
People
Related News
09 October 2024
In the News
Jason Mehta Weighs in on SEC Settlements, Clinical Research Fraud
Foley & Lardner LLP partner Jason Mehta commented on a recent health care litigation settlement with the U.S. Securities and Exchange Commission in the Clinical Trials Arena article, “Cassava Sciences: Phase III trials storm ahead amid controversy.”
08 October 2024
In the News
John Strom Assesses BIOSECURE ACT – 'Going to be tough to navigate'
Foley & Lardner LLP special counsel John Strom shared insight on the potential impact of the BIOSECURE ACT in the BioSpaces article, "WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow."
08 October 2024
In the News
Anil Shankar Shares Insight on Proposition 34, Impact to 340B Program
Foley & Lardner LLP partner Anil Shankar offered insight on California's Proposition 34, a ballot measure this election season, in the KCRW article, "Confused on Prop 34? It’s about the politics of rent control."